Phenominer Database Results (63 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
SD-Fhem1+/- blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount female 0 days 3 35.8 U/l 6.64 11.5 automated blood analysis 0.0 0 104928 2989
SD-Fhem1+/- blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount female 0 days 3 1.8 U/l 0.29 0.5 automated blood analysis 0.0 0 104936 2989
SD-Fhem1+/- platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity male 0 days 3 1004.0 x 1000 cells/ul 80.6 139.6 automated blood analysis 0.0 0 104863 2989
SD-Fhem1+/- mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 51.4 fl 0.64 1.1 automated blood analysis 0.0 0 104876 2989
SD-Fhem1+/- blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 0.03 x 1000 cells/ul 0.0 0.0 automated blood analysis 0.0 0 104908 2989
SD-Fhem1+/- blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount female 0 days 3 108.0 mg/dl 12.47 21.6 automated blood analysis 0.0 0 104968 2989
SD-Fhem1+/- white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 3.0 x 1000 cells/ul 0.23 0.4 automated blood cell counting method 0.0 0 104836 2989
SD-Fhem1+/- blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount female 0 days 3 677.0 g/dl 16.74 29.0 automated blood analysis 0.0 0 104956 2989
SD-Fhem1+/- blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity male 0 days 3 3.3 % 0.4 0.7 automated blood analysis 0.0 0 104891 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 11.7 % 2.19 3.8 automated blood analysis 0.0 0 104923 2989
SD-Fhem1+/- blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount male 0 days 3 124.3 U/l 5.6 9.7 automated blood analysis 0.0 0 104931 2989
SD-Fhem1+/- plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 -0.6 umol/l 0.12 0.2 automated blood analysis 0.0 0 104951 2989
SD-Fhem1+/- blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount male 0 days 3 640.0 g/dl 7.51 13.0 automated blood analysis 0.0 0 104955 2989
SD-Fhem1+/- blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount male 0 days 3 301.0 g/dl 6.35 11.0 automated blood analysis 0.0 0 104963 2989
SD-Fhem1+/- platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity female 0 days 3 964.3 x 1000 cells/ul 62.24 107.8 automated blood analysis 0.0 0 104864 2989
SD-Fhem1+/- blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 1.7 x 1000 cells/ul 0.52 0.9 automated blood analysis 0.0 0 104899 2989
SD-Fhem1+/- red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 19.6 % 0.81 1.4 automated blood analysis 0.0 0 104915 2989
SD-Fhem1+/- blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount male 0 days 3 43.7 U/l 3.29 5.7 automated blood analysis 0.0 0 104927 2989
SD-Fhem1+/- blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount female 0 days 3 100.5 U/l 5.66 9.8 automated blood analysis 0.0 0 104932 2989
SD-Fhem1+/- plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 -0.2 umol/l 0.17 0.3 automated blood analysis 0.0 0 104952 2989
SD-Fhem1+/- blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount female 0 days 3 305.0 g/dl 4.62 8.0 automated blood analysis 0.0 0 104964 2989
SD-Fhem1+/- blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount female 0 days 3 920.0 mg/dl 57.74 100.0 automated blood analysis 0.0 0 104972 2989
SD-Fhem1+/- blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount male 0 days 3 41.0 IU/l 0.58 1.0 automated blood analysis 0.0 0 104983 2989
SD-Fhem1+/- mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 8.1 fl 0.29 0.5 automated blood analysis 0.0 0 104867 2989
SD-Fhem1+/- blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 1450.0 g/dl 40.41 70.0 automated blood analysis 0.0 0 104855 2989
SD-Fhem1+/- mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 8.7 fl 0.23 0.4 automated blood analysis 0.0 0 104868 2989
SD-Fhem1+/- blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 57.8 % 4.56 7.9 automated blood analysis 0.0 0 104888 2989
SD-Fhem1+/- blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity female 0 days 3 3.6 % 0.46 0.8 automated blood analysis 0.0 0 104892 2989
SD-Fhem1+/- blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 0.1 x 1000 cells/ul 0.0 0.0 automated blood analysis 0.0 0 104904 2989
SD-Fhem1+/- blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 0.04 x 1000 cells/ul 0.03 0.06 automated blood analysis 0.0 0 104907 2989
SD-Fhem1+/- red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 28.0 % 0.98 1.7 automated blood analysis 0.0 0 104911 2989
SD-Fhem1+/- red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 16.0 % 0.69 1.2 automated blood analysis 0.0 0 104916 2989
SD-Fhem1+/- blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 1.0 % 0.52 0.9 automated blood analysis 0.0 0 104895 2989
SD-Fhem1+/- blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount male 0 days 3 1.3 U/l 0.35 0.6 automated blood analysis 0.0 0 104935 2989
SD-Fhem1+/- plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 0.4 umol/l 0.12 0.2 automated blood analysis 0.0 0 104948 2989
SD-Fhem1+/- blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount male 0 days 3 810.0 mg/dl 28.87 50.0 automated blood analysis 0.0 0 104971 2989
SD-Fhem1+/- blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 1.0 % 0.06 0.1 automated blood analysis 0.0 0 104896 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 16.5 % 1.44 2.5 automated blood analysis 0.0 0 104921 2989
SD-Fhem1+/- blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount male 0 days 3 38.0 U/l 5.43 9.4 automated blood analysis 0.0 0 104940 2989
SD-Fhem1+/- hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 41.7 % 0.92 1.6 automated blood analysis 0.0 0 104860 2989
SD-Fhem1+/- mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 16.2 pg 0.29 0.5 automated blood analysis 0.0 0 104879 2989
SD-Fhem1+/- red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 8.9 x 10E6 cells/ul 0.17 0.3 automated blood cell counting method 0.0 0 104839 2989
SD-Fhem1+/- red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 8.1 x 10E6 cells/ul 0.17 0.3 automated blood cell counting method 0.0 0 104840 2989
SD-Fhem1+/- blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount female 0 days 3 373.0 g/dl 12.7 22.0 automated blood analysis 0.0 0 104960 2989
SD-Fhem1+/- blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 1450.0 g/dl 40.41 70.0 automated blood analysis 0.0 0 104856 2989
SD-Fhem1+/- blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 0.4 x 1000 cells/ul 0.29 0.5 automated blood analysis 0.0 0 104903 2989
SD-Fhem1+/- red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 25.6 % 0.69 1.2 automated blood analysis 0.0 0 104912 2989
SD-Fhem1+/- mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 3443.0 g/dl 23.67 41.0 automated blood analysis 0.0 0 104883 2989
SD-Fhem1+/- mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 3433.0 g/dl 12.7 22.0 automated blood analysis 0.0 0 104884 2989
SD-Fhem1+/- blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 50.7 % 4.04 7.0 automated blood analysis 0.0 0 104887 2989
SD-Fhem1+/- platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 8.9 fl 0.58 1.0 automated blood analysis 0.0 0 104919 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 16.1 % 1.62 2.8 automated blood analysis 0.0 0 104924 2989
SD-Fhem1+/- plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 0.3 umol/l 0.12 0.2 automated blood analysis 0.0 0 104947 2989
SD-Fhem1+/- blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount female 0 days 3 34.5 IU/l 3.23 5.6 automated blood analysis 0.0 0 104984 2989
SD-Fhem1+/- white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 3.2 x 1000 cells/ul 0.52 0.9 automated blood cell counting method 0.0 0 104835 2989
SD-Fhem1+/- blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount male 0 days 3 339.0 g/dl 5.2 9.0 automated blood analysis 0.0 0 104959 2989
SD-Fhem1+/- hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 42.1 % 0.92 1.6 automated blood analysis 0.0 0 104859 2989
SD-Fhem1+/- mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 47.2 fl 0.81 1.4 automated blood analysis 0.0 0 104875 2989
SD-Fhem1+/- mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 17.7 pg 0.23 0.4 automated blood analysis 0.0 0 104880 2989
SD-Fhem1+/- blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 1.8 x 1000 cells/ul 0.29 0.5 automated blood analysis 0.0 0 104900 2989
SD-Fhem1+/- platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 9.8 fl 0.4 0.7 automated blood analysis 0.0 0 104920 2989
SD-Fhem1+/- blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount male 0 days 3 69.3 U/l 2.6 4.5 automated blood analysis 0.0 0 104939 2989
SD-Fhem1+/- blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount male 0 days 3 129.6 mg/dl 4.16 7.2 automated blood analysis 0.0 0 104967 2989